Jane Street Group, LLC I Bio, Inc. Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $1,335 - $928,800	5,805 Added 26.82%	27,452 $5,000
Q2 2022 Aug 16, 2022	SELL	$0.23 - $0.46 $11,693 - $23,387	-50,843 Reduced 70.14%	21,647 $6,000
Q1 2022 May 17, 2022	SELL	$0.3 - $0.61 $27,546 - $56,010	-91,821 Reduced 55.88%	72,490 $31,000
Q4 2021 Feb 15, 2022	BUY	$0.55 - $1.04 $54,225 - $102,535	98,592 Added 150.02%	164,311 $91,000
Q3 2021 Nov 16, 2021	BUY	$1.06 - $1.52 $7,176 - $10,290	6,770 Added 11.48%	65,719 $70,000
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $13,640 - $18,448	11,181 Added 23.41%	58,949 $89,000
Q1 2021 May 18, 2021	SELL	$1.18 - $2.62 $26,824 - $59,560	-22,733 Reduced 32.24%	47,768 $74,000
Q4 2020 Feb 17, 2021	BUY	$1.05 - $2.24 $74,026 - $157,922	70,501 New	70,501 $74,000
Q3 2020 Nov 17, 2020	SELL	$1.7 - $6.41 $549,552 - $2.07 Million	-323,266 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.87 - $2.46 $194,205 - $549,133	223,225 Added 223.13%	323,266 $718,000
Q1 2020 May 15, 2020	BUY	$0.22 - $2.45 $22,009 - $245,100	100,041 New	100,041 $106,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.